EV/EBITDA
-1.64
-0.08-5.13%
17 min ago
Summary
- As of February 28, 2025, CMMB EV/EBITDA is -1.64, with a fall of -0.08 (-5.13%) during the most recent trading day.
- Over the past year, CMMB EV/EBITDA has dropped by -1.63 (-16300.00%).
- CMMB EV/EBITDA is now -646.67% below its all-time high of 0.30.
Performance
CMMB EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CMMB EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -5.1% | +5.5% | +4.4% |
| 1 m1 month | +26.1% | -26.0% | -22.0% |
| 3 m3 months | +4.1% | -4.3% | -3.5% |
| 6 m6 months | +9.4% | -13.0% | -8.2% |
| ytdytd | +8.9% | -8.9% | -7.2% |
| 1 y1 year | -10000.0% | +7165.9% | +156.5% |
| 5 y5 years | - | - | -88.4% |
CMMB EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -10.8% | -2.22 | +26.1% | |
| 3 m | 3-month | -1.48 | -10.8% | -2.50 | +34.4% |
| 6 m | 6-month | -0.93 | -76.3% | -2.58 | +36.4% |
| 1 y | 1-year | -0.01 | <-9999.0% | -2.58 | +36.4% |
| 3 y | 3-year | 0.30 | -646.7% | -3.71 | +55.8% |
| 5 y | 5-year | 0.30 | -646.7% | -32.26 | +94.9% |
| alltime | all time | 0.30 | -646.7% | -32.26 | +94.9% |
Chemomab Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -1.64(-8.9%) |
| 2024 | -1.80(-2671.4%) |
| Date | Value |
|---|---|
| 2023 | 0.07(-109.1%) |
| 2022 | -0.77(-85.1%) |
| 2021 | -5.18 |
FAQ
- What is Chemomab Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Chemomab Therapeutics?
- What is CMMB EV/EBITDA year-to-date change?
- What is Chemomab Therapeutics EV/EBITDA year-on-year change?
What is Chemomab Therapeutics EV/EBITDA?
The current EV/EBITDA of CMMB is -1.64
What is the all time high EV/EBITDA for Chemomab Therapeutics?
Chemomab Therapeutics all-time high EV/EBITDA is 0.30
What is CMMB EV/EBITDA year-to-date change?
Chemomab Therapeutics EV/EBITDA has changed by +0.16 (+8.89%) since the beginning of the year
What is Chemomab Therapeutics EV/EBITDA year-on-year change?
Over the past year, CMMB EV/EBITDA has changed by -1.63 (-16300.00%)